IP Library Granted Patent US 10,829,733
Granted Patent B2
US 10,829,733 · App. 12/725,877 · Granted Nov 10, 2020

Composition and method for enabling proliferation of pluripotent human stem cells

Inventors: Karl Tryggvason (Djursholm, SE); Sergey Rodin (Stockholm, SE); Anna Domogatskaya (Rönninge, SE)
Assignee: BIOLAMINA AB
C12N5/0606C12N2500/25C12N2500/90C12N2500/98C12N2501/115C12N2501/998C12N2533/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,829,733
App. No.
12/725,877
Granted
Nov 10, 2020
Kind
B2
Abstract

Compositions and processes for culturing human stem cells in vitro in an undifferentiated state are disclosed. In this regard, human embryonic stem cells proliferated and maintained their pluripotency when cultured on plates coated with recombinant laminin-10 (laminin-511).

Claims (23)

1. A method for creating a new pluripotent human stem cell line in a defined and xeno-free environment comprising:

providing a substrate comprising a coating that is devoid of both animal proteins and feeder cells, and the coating comprises a single isoform of a full-length laminin consisting of laminin-511 (LN-511 or laminin-10);

plating cells from a blastocyst inner cell mass comprising pluripotent human stem cells onto the coating;

exposing the pluripotent human stem cells to a chemically defined medium that is devoid of feeder cells; and

obtaining a new pluripotent human stem cell line from outgrowth of the human stem cells.

2. The method of claim 1 , wherein the new pluripotent human stem cell line is non-differentiated.

3. The method of claim 1 , wherein the new pluripotent human stem cell line is homogeneous.

4. The method of claim 1 , wherein the new pluripotent human stem cell line forms monolayers on the coating.

5. The method of claim 1 , wherein the new pluripotent human stem cell line comprises non-differentiated embryonic stem cells.

6. The method of claim 1 , further comprising:

harvesting the new pluripotent human stem cell line;

replating the new pluripotent human stem cell line on a second substrate comprising the coating;

exposing the new pluripotent human stem cell line to a chemically defined medium that is devoid of feeder cells; and

obtaining refined pluripotent human stem cells from outgrowth of the new pluripotent human stem cell line.

7. The method of claim 1 , wherein the medium further comprises a growth factor.

8. A method for maintaining self-renewing pluripotent human stem cells, comprising:

a) providing a substrate comprising a coating that is devoid of both animal proteins and feeder cells, and the coating comprises only a single isoform of a laminin consisting of intact laminin-511 (LN-511 or laminin-10);

b) plating pluripotent human stem cells onto the coating;

c) exposing the pluripotent human stem cells to a chemically defined medium that is devoid of feeder cells, thereby maintaining self-renewing pluripotent human stem cells; and

d) periodically harvesting and replating the pluripotent human stem cells.

9. The method of claim 8 , wherein the medium further comprises a growth factor.

10. The method of claim 8 , wherein the pluripotent human stem cells from step c) form monolayers on the coating.

11. The method of claim 8 , wherein the pluripotent human stem cells are non-differentiated embryonic stem cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2014
From: TRYGGVASON, KARL; DOMOGATSKAYA, ANNA; RODIN, SERGEY
To: BIOLAMINA AB
Reel/Frame 033463/0862 →
Continuity (3)
Continuation In Part 11969620 · Jan 4, 2008
Provisional Application 60883406 · Jan 4, 2007
Related Publication 20100203635A1 · Aug 12, 2010